SENSOMAT
by Biochem International, Inc. 2 variants
510(k) K771722
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK771722 | Date26 Sep 1977 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CCC
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.1150
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The SENSOMAT is a Blood-Phase, Indwelling Analyzer, Gas, Carbon-Dioxide, Partial Pressure, designed to measure the partial pressure of carbon dioxide (PCO₂) in arterial or venous blood. This device is classified under Regulation 868.1150 and falls within the Anesthesiology specialty, providing critical monitoring for respiratory gas exchange during anesthesia and intensive care procedures.
The SENSOMAT is supplied as a reusable medical device, intended for use in clinical settings such as operating rooms and critical care units. It operates under FDA 510(k) clearance (K771722, K803014) and adheres to Class 2 regulatory standards, with product codes CCC and CBZ depending on the submission. No specific sterility or MRI safety information is provided in the available data.
Other devices from Biochem International, Inc.
Questions
AI-generated answers, 19 Sep 2026
What clinical settings is the SENSOMAT intended for use in, and how does it support patient monitoring during those procedures?
The SENSOMAT is designed for use in clinical settings like operating rooms and critical care units, where real-time monitoring of respiratory gas exchange is essential. It measures the partial pressure of carbon dioxide (PCO₂) in arterial or venous blood, providing critical data during anesthesia and intensive care procedures to ensure proper ventilation and oxygenation of patients.
Is the SENSOMAT a single-use or reusable device, and what does this mean for maintenance and cost considerations?
The SENSOMAT is a reusable medical device, meaning it is intended for repeated use after proper cleaning, disinfection, and maintenance. This design can reduce per-procedure costs compared to single-use alternatives, though it requires adherence to facility protocols for reprocessing and sterilization to ensure safety and performance.
What regulatory pathway was followed for the SENSOMAT’s FDA clearance, and how does this classification impact its use?
The SENSOMAT was cleared through the FDA’s 510(k) pathway, specifically under Traditional review (K771722, K803014), and is classified as a Class 2 device. This classification means it is subject to general controls and special controls for blood gas analyzers, ensuring it meets performance standards for measuring PCO₂ in clinical settings like anesthesia and intensive care.
Are there specific storage requirements for the SENSOMAT, and how should it be handled to maintain accuracy and reliability?
The provided data does not specify storage requirements for the SENSOMAT, but as a reusable medical device, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures. Proper handling, including regular calibration and maintenance, is critical to ensure accurate PCO₂ measurements during patient monitoring.